DCGI has allowed Bharat Biotech to conduct phase I and II human trials for COVAXIN that will begin in July; a finished vaccine is expected to be rolled out in 3-4 months if all goes according to plan
DCGI has allowed Bharat Biotech to conduct phase I and II human trials for COVAXIN that will begin in July; a finished vaccine is expected to be rolled out in 3-4 months if all goes according to plan